Fen-Phen User Fairly Denied Extra Benefits, 3rd Circ. Finds
The Third Circuit on Tuesday ruled that the trust overseeing a national class action settlement over the drug combination fen-phen is correctly interpreting a key aspect of the agreement, rejecting a...To view the full article, register now.
Already a subscriber? Click here to view full article